Insider Trading & Ownership of Novo Holdings A/S

Location
Hellerup
Summary
The estimated value of insider holdings of Novo Holdings A/S is at least $477,431,383 dollars as of 30 Oct 2025. Novo Holdings A/S is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $222M. Novo Holdings A/S is the 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $95.78M. Novo Holdings A/S is the 10%+ Owner of Disc Medicine, Inc. and owns shares of Disc Medicine, Inc. (IRON) stock worth about $73.79M. Novo Holdings A/S is the 10%+ Owner of Checkmate Pharmaceuticals, Inc. and owns shares of Checkmate Pharmaceuticals, Inc. stock worth about $22.59M. Novo Holdings A/S is the 10%+ Owner of Reneo Pharmaceuticals, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $20.9M. Novo Holdings A/S is the 10%+ Owner of Inogen Inc and owns shares of Inogen Inc (INGN) stock worth about $11.89M. Novo Holdings A/S is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. stock worth about $7.93M. Novo Holdings A/S is the 10%+ Owner of Cyteir Therapeutics, Inc. and owns shares of Cyteir Therapeutics, Inc. stock worth about $5.95M. Novo Holdings A/S is the 10%+ Owner of IO Biotech, Inc. and owns shares of IO Biotech, Inc. (IOBT) stock worth about $5.71M. Novo Holdings A/S is the 10%+ Owner of Metagenomi, Inc. and owns shares of Metagenomi, Inc. (MGX) stock worth about $5.01M. Novo Holdings A/S is the 10%+ Owner of Bolt Biotherapeutics, Inc. and owns shares of Bolt Biotherapeutics, Inc. (BOLT) stock worth about $3.52M. Novo Holdings A/S is the 10%+ Owner of SPRUCE BIOSCIENCES, INC. and owns shares of SPRUCE BIOSCIENCES, INC. (SPRB) stock worth about $1.92M. Novo Holdings A/S is the 10%+ Owner of MINERVA SURGICAL INC and owns shares of MINERVA SURGICAL INC (UTRS) stock worth about $420.9K.
Signature
/s/ Barbara Fiorini, General Counsel, Finance & Operations of Novo Holdings A/S
All Insider Reports
All Insider Reports

Notify me when Novo Holdings A/S files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Novo Holdings A/S

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACLX Arcellx, Inc. 10%+ Owner $222,004,412 08 Feb 2022
EWTX Edgewise Therapeutics, Inc. 10%+ Owner $95,781,722 14 Sep 2022
IRON Disc Medicine, Inc. 10%+ Owner $73,790,726 28 Jun 2023
CMPI Checkmate Pharmaceuticals, Inc. 10%+ Owner $22,592,579 23 Feb 2022
OKUR Reneo Pharmaceuticals, Inc. 10%+ Owner $20,900,196 23 Jun 2023
INGN Inogen Inc 10%+ Owner $11,893,710 02 Jun 2021
VERV Verve Therapeutics, Inc. 10%+ Owner $7,932,650 21 Jun 2021
CYT Cyteir Therapeutics, Inc. 10%+ Owner $5,952,410 19 Jul 2023
IOBT IO Biotech, Inc. 10%+ Owner $5,709,989 25 Jul 2024
MGX Metagenomi, Inc. 10%+ Owner $5,008,824 09 Feb 2024
BOLT Bolt Biotherapeutics, Inc. 10%+ Owner $3,518,791 13 Jul 2022
SPRB SPRUCE BIOSCIENCES, INC. 10%+ Owner $1,924,485 21 Mar 2024
UTRS MINERVA SURGICAL INC 10%+ Owner $420,889 26 Oct 2021
MPLT MapLight Therapeutics, Inc. 10%+ Owner 28 Oct 2025

Insider Transactions Reported by Novo Holdings A/S:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.